Diabetes
Which diabetes drug is best?
(HealthDay)—No single drug to treat type 2 diabetes stands out from the pack when it comes to reducing the risks of heart disease, stroke or premature death, a new research review finds.
Jul 19, 2016
0
20
News tagged with combined heart
Medications
FDA approves first diabetes-cholesterol combo pill
(AP) -- The first combination pill for the millions of people with the dangerous combination of diabetes and high cholesterol won U.S. approval Friday, offering convenience - and savings - to patients taking multiple pills.
Oct 7, 2011
0
0
Cardiology
More than one-third of patients risk major bleeding by doubling up on blood thinners
A daily aspirin is a commonly used, generally safe therapy for people who need help preventing heart attacks or stroke.
Mar 4, 2019
0
24
Cardiology
A polypill strategy to improve global secondary cardiovascular prevention
The polypill, a combination pill taken just once a day that includes key medications for secondary prevention of heart disease, may be an effective low-cost strategy to improve adherence to medication recommendations and ...
Aug 4, 2014
0
0
Medications
Elevated cholesterol levels: Benefit of ezetimibe is not proven
Elevated blood cholesterol levels are regarded as a risk factor for heart attacks and other cardiovascular diseases. However, this does not necessarily mean that every cholesterol-lowering drug can also prevent heart attacks. ...
Sep 14, 2011
0
0
Cardiology
International trial finds polypill halves predicted heart disease and stroke risk
The world's first international polypill trial has shown that a four-in-one combination pill can halve the predicted risk of heart disease and stroke. The results are published online today in the open access journal PLoS ...
May 25, 2011
0
0
Cardiology
Niacin therapy unhelpful, occasionally harmful, study says
A combination drug containing niacin failed to lower the risk of heart attacks or strokes and even proved harmful for some with vascular disease, a study released Saturday reported.
Mar 9, 2013
0
0
Cardiology
Stopping aspirin three months after stenting does not increase risk of death
Patients who stopped taking aspirin three months after receiving a stent to open the heart's arteries but continued taking a P2Y12 inhibitor—clopidogrel, prasugrel or ticagrelor—did not experience higher rates of death ...
Mar 18, 2019
0
1
Immunology
Researchers create new combination vaccine to fight Streptococcus A
Griffith University's Institute for Glycomics has developed a groundbreaking, combination vaccine that may finally beat Streptococcus A infections.
Jun 1, 2015
0
185
Psychology & Psychiatry
Study: Exercise probably best treatment for depression in coronary heart disease
A study by RCSI indicates that exercise is probably the most effective short-term treatment for depression in people with coronary heart disease, when compared to antidepressants and psychotherapy or more complex care.
Jun 8, 2021
0
0
